~ Buy the VARITHENA (polidocanol) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR VARITHENA

All Clinical Trials for VARITHENA

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02054325 ↗	Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins	Completed	Fundação de Amparo à Pesquisa do Estado de São Paulo	Phase 4	2012-09-01	It will be done a randomized triple-blind study comparing 0,2% polidocanol versus 75% hypertonic glucose of sclerotherapy in lower limbs´ reticular veins. It will be included only adult women with reticular veins on the side of the thighs and mild venous insufficiency (CEAP 1). The primary endpoint will be efficacy, and secondary will be safety.
NCT02054325 ↗	Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins	Completed	UPECLIN HC FM Botucatu Unesp	Phase 4	2012-09-01	It will be done a randomized triple-blind study comparing 0,2% polidocanol versus 75% hypertonic glucose of sclerotherapy in lower limbs´ reticular veins. It will be included only adult women with reticular veins on the side of the thighs and mild venous insufficiency (CEAP 1). The primary endpoint will be efficacy, and secondary will be safety.
NCT02462720 ↗	COMFORT: A Multicenter, Open-label, Randomized, Crossover Study	Completed	Boston Scientific Corporation	Phase 4	2015-05-01	The purpose of this study is to evaluate pain the patient experienced following treatment of varicose veins with Varithena® compared to radiofrequency ablation.
NCT02462720 ↗	COMFORT: A Multicenter, Open-label, Randomized, Crossover Study	Completed	BTG International Inc.	Phase 4	2015-05-01	The purpose of this study is to evaluate pain the patient experienced following treatment of varicose veins with Varithena® compared to radiofrequency ablation.
NCT02657252 ↗	Polidocanol Versus Glucose Treatment of Telangiectasia Trial	Completed	Fundação de Amparo à Pesquisa do Estado de São Paulo	Phase 4	2015-01-01	It will be done a randomized triple-blind study comparing 0,2% polidocanol versus 75% hypertonic glucose of sclerotherapy in lower limbs´ telangiectasis. It will be included only adult women with reticular veins on the side of the thighs and mild venous insufficiency (CEAP 1). The primary endpoint will be efficacy, and secondary will be safety.
NCT02657252 ↗	Polidocanol Versus Glucose Treatment of Telangiectasia Trial	Completed	UPECLIN HC FM Botucatu Unesp	Phase 4	2015-01-01	It will be done a randomized triple-blind study comparing 0,2% polidocanol versus 75% hypertonic glucose of sclerotherapy in lower limbs´ telangiectasis. It will be included only adult women with reticular veins on the side of the thighs and mild venous insufficiency (CEAP 1). The primary endpoint will be efficacy, and secondary will be safety.

Clinical Trial Conditions for VARITHENA

Condition Name

Condition Name for VARITHENA
Intervention	Trials
Varicose Veins	5
Varicose Veins Leg	1
Veins, Varicose	1
Venous Leg Ulcer	1

Condition MeSH

Condition MeSH for VARITHENA
Intervention	Trials
Varicose Veins	5
Leg Ulcer	1
Gastroesophageal Reflux	1
Telangiectasis	1

Clinical Trial Locations for VARITHENA

Trials by Country

Trials by Country for VARITHENA
Location	Trials
United States	5
Brazil	2

Trials by US State

Trials by US State for VARITHENA
Location	Trials
Ohio	1
Washington	1
New York	1
Illinois	1
Florida	1

Clinical Trial Progress for VARITHENA

Clinical Trial Phase

Clinical Trial Phase for VARITHENA
Clinical Trial Phase	Trials
Phase 4	5

Clinical Trial Status

Clinical Trial Status for VARITHENA
Clinical Trial Phase	Trials
Completed	3
Not yet recruiting	1
Withdrawn	1

Clinical Trial Sponsors for VARITHENA

Sponsor Name

Sponsor Name for VARITHENA
Sponsor	Trials
Fundação de Amparo à Pesquisa do Estado de São Paulo	2
UPECLIN HC FM Botucatu Unesp	2
Boston Scientific Corporation	2

Sponsor Type

Sponsor Type for VARITHENA
Sponsor	Trials
Other	7
Industry	2